Android Apple

Institutional investors in Trevi Therapeutics, Inc. (NASDAQ:TRVI) see US$40m decrease in market cap last week, although long-term gains have benefitted them.

By Yahoo! Finance   |   4 months ago
Institutional investors in Trevi Therapeutics, Inc. (NASDAQ:TRVI) see US$40m decrease in market cap last week, although long-term gains have benefitted them.

Ownership research and analyst forecasts data provide insights into stock opportunities. Institutions hold 37% stake in Trevi Therapeutics, impacting market cap fluctuations. Hedge funds and private equity firms also play significant roles in influencing company decisions.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.